Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04348851 · ClinicalTrials.gov registry record · NA

Internet and Telephone Support Intervention for Stroke Caregivers

A NA study of Depression and Stress, sponsored by VA Office of Research and Development.

Completed
Registry status
NA
Development phase
53
Enrollment target
1
Study location

NCT04348851: Completed NA study of Depression and Stress, sponsored by VA Office of Research and Development.

NCT04348851 is a NA study of Depression and Stress that has completed, run by VA Office of Research and Development. The registered enrollment target is 53 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04348851, a NA study of Depression and Stress, has completed, sponsored by VA Office of Research and Development.

COMPLETED
Registry status
NA
Development phase
53 participants
Enrollment target
1
Study location

Study Summary

This study will test a problem-solving and support intervention for caregivers of veterans with stroke. The investigators will assign caregivers to one for four groups: 4-session intervention, 8-session intervention, attention control (active listening), or standard care. The investigators will assess the impact of the intervention on caregiver outcomes (depression, burden, stress, problem-solving abilities, self-efficacy, and quality of life) and veteran outcomes (functional abilities).

Primary Outcome

Changes in depressive symptoms will be measured with the Center for Epidemiologic Studies Depression (CES-D) scale. The CES-D is a 20-item, 4-point Likert scale ranging from never (0) to most of the time (3). Possible scores range from 0-60 with higher scores indicating more symptoms. It has been used in numerous studies with caregivers and has good reliability and validity.

Interventions

  • BEHAVIORAL Attention Control
  • BEHAVIORAL Caregiver problem-solving

Study Locations (1)

Florida

  • North Florida/South Georgia Veterans Health System, Gainesville, FL - Gainesville

Trial Details

FieldValue
Enrollment Target 53 participants
Start Date 2014-10-01
Est. Completion 2016-10-01
Phase NA
VA Office of Research and Development

1,668 total trials

What the finished NCT04348851 record still lists

NCT04348851 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 53 participants, a relatively small participant target, below the 786-participant average among 679 other Depression trials with a reported enrollment target (93% lower).

The record links to 5 conditions, with Depression appearing as the primary indexed condition, and to 2 interventions - of which Attention Control is the first listed.

NCT04348851 reports a single indexed study location in Florida.

Frequently Asked Questions

What is clinical trial NCT04348851 about?

NCT04348851 is a clinical study titled "Internet and Telephone Support Intervention for Stroke Caregivers". This study will test a problem-solving and support intervention for caregivers of veterans with stroke. The investigators will assign caregivers to one for four groups: 4-session intervention, 8-session intervention, attention control (active listening), or standard care. The investigators will asse...

What is the current status of trial NCT04348851?

This trial is currently completed. It is a NA study. The enrollment target is 53 participants. The study started on 2014-10-01. Estimated completion is 2016-10-01.

What conditions does trial NCT04348851 study?

This clinical trial studies the following conditions: Depression, Stress, Quality of Life, Self Efficacy, Recovery of Function.

What interventions are being tested in trial NCT04348851?

The interventions under investigation include: Attention Control (BEHAVIORAL), Caregiver problem-solving (BEHAVIORAL).

Who is sponsoring clinical trial NCT04348851?

This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04348851 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Depression

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04348851's enrollment target sits among peer trials

53 462nd of 679 higher than 216 of 679 other Depression trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Depression trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04177004 · 53 participants · Phase 1

    Human Lysozyme Goat Milk for the Prevention of Graft Versus Host Disease in Patients With Blood Cancer Undergoing a Donor Stem Cell Transplant

  • NCT04199741 · 53 participants · Phase 1

    PET/CT Imaging of Small Cell Lung Cancer Using 89Zr-DFO-SC16.56

  • NCT04835129 · 53 participants · Phase 2

    Isatuximab, Pomalidomide, Elotuzumab and Dexamethasone in Relapsed and/or Refractory Multiple Myeloma

  • NCT04913805 · 53 participants · Phase 2

    Matching Perfusion and Metabolic Activity in HFpEF

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT06358040 · started 2026-10 · NA

    Opioid Dispenser for Microdiscectomy/Laminectomy

Source: ClinicalTrials.gov NCT04348851, the US trial registry maintained by the National Library of Medicine. NCT04348851 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.